Lucian C. Chen practices a broad range of intellectual property law with an emphasis on complex pharmaceutical and biotechnology patent litigation. He is a litigator with over a decade of experience representing clients in multibillion-dollar patent litigation cases involving products as varied as antifungals, antibiotics, osteoporosis therapies, oral contraceptives, and cholinesterase inhibitors. His extensive involvement in all aspects of patent litigation spans counseling clients and initiating litigation, through to both bench and jury trials.

Mr. Chen also has significant experience in preparing pre-suit investigations, non-infringement opinions, licensing and settlement agreements and intellectual property due diligence. In addition, he has prepared trademark applications and counseled clients in copyright disputes.

Prior to becoming an attorney, Mr. Chen was Founding Editor-in-Chief of BioProcessing, a peer-reviewed journal focusing on the industrial biotechnology industry. His decade-long journalism career includes experience as Associate Managing Editor of Genetic Engineering News, the leading trade publication of the biotechnology field, as well as Managing Director and Editor for a group of science websites in the VerticalNet e-commerce family.

EDUCATION

• St. John’s University School of Law, Juris Doctor
• Columbia University, Master of Public Health in Health Policy and Management
• The Johns Hopkins University, Bachelor of Arts in Biology

BAR ADMISSIONS

• State of New York
• United States Supreme Court
• United States Patent and Trademark Office
• United States District Court for the Southern District of New York
• United States District Court for the Eastern District of New York

PROFESSIONAL ACTIVITIES

• American Bar Association
• New York State Bar Association
• New York Intellectual Property Law Association
• National Asian Pacific American Bar Association
• National Association of Science Writers
• Society for Professional Journalists

REPRESENTATIVE PUBLICATIONS

• Patenting Nanotech Inventions: Strategic Early Positioning May Protect Portfolio Once Litigation Emerges. Industrial Biotechnology (2005)
• Enablement in the Spotlight: Federal Circuit applied foreseeability standard for
• biotech patents. National Law Journal (2003)
• Chemdex Closing, Shifts E-Marketplace Picture. Genetic Engineering News (2001)
• Mass Spec Leads News from PittCon: Life Scientists Welcome Increased Data. Genetic Engineering News (2000
• PE and HP to Divide Operations: Both Realignments Will Allow the Companies to Focus on Core Business. Genetic Engineering News (1999)
• Modulation of epidermal growth factor receptors by gamma interferon in a breast cancer cell line. Anticancer Research (1991)
• Enhancement of anchorage independent growth of a human adrenal carcinoma cell line by endogenously produced basic fibroblast growth factor. International Journal of Cancer (1990)

Lucian C. Chen
Main:  646.308.1607 Extension 7
Direct:  646.308.1624